Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bahram Valamehr Insider Profile
4 Followers
Bahram Valamehr, Chief R&D Officer at Fate Therapeutics, holds 158.07K shares in Fate Therapeutics (Ticker: FATE). Most recently, Bahram Valamehr Sold $11,271 shares of Fate Therapeutics on Jan 10, 2024 for an estimated value of 49.37K.
Bahram Valamehr Fate Therapeutics (FATE)Chief R&D Officer
Fate Therapeutics (FATE)
Chief R&D Officer
Ranked #94,390 out of 98,743 Corporate Insiders
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
-53.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bahram Valamehr's holdings
Insider Roles
Chief R&D Officer
Roles that Bahram Valamehr holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bahram Valamehr
Bahram Valamehr's Trading History
List of latest transactions for each holding click on a transaction to see Bahram Valamehr's performance on stock
You May Also Like
Bahram Valamehr insider profile FAQ
What is the percentage of profitable transactions made by Bahram Valamehr?
The percentage of profitable transactions made by Bahram Valamehr is 63%.
What is the average return per transaction made by Bahram Valamehr?
The average return per transaction made by Bahram Valamehr is -53.60%.
What stocks does Bahram Valamehr hold?
Bahram Valamehr holds: FATE stocks.
What was Bahram Valamehr’s latest transaction?
Bahram Valamehr latest transaction was an Informative Sell of $49.37K.
What was Bahram Valamehr's most profitable transaction?
Bahram Valamehr’s most profitable transaction was an Informative Sell of FATE stock on January 13, 2022. The return on the trade was 87.20%.
What is Bahram Valamehr's role in Fate Therapeutics?
Bahram Valamehr's role in Fate Therapeutics is Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.